期刊文献+

平和质酒精性股骨头坏死患者CYP4501A2*1C基因多态性研究 被引量:6

Gene Polymorphism of CYP4501A2*1C in Patients with Alcoholic Avascular Necrosis of the Femoral Head of Yin-yang Balanced Physique
原文传递
导出
摘要 目的:研究平和质酒精性股骨头坏死患者CYP4501A2*1C的基因多态性,探讨平和质及CYP4501A2*1C与酒精性股骨头坏死发病的相关性。方法:对酒精性股骨头坏死的患者进行中医体质问卷调查,确定高发体质(平和质)进行CYP4501A2*1C基因多态性检测并与非股骨头坏死正常人群(对照组)作对照。结果:平和质酒精性股骨头坏死(平和质组)和非股骨头坏死正常人群(对照组)中共检测出多态性位点5处,平和质组在135位点检出A碱基占10.87%,G碱基占89.13%;149位点插入一个C碱基;397位点检出T碱基占10.87%,G碱基占89.13%;401位点检出T碱基占79.35%,G碱基占20.65%;494位点检出杂合子GA占1.09%,纯合子GG碱基占1.09%;杂合子CG占97.82%;对照组在135位点检出A碱基占12.5%,G碱基占87.5%;149位点无碱基插入;397位点检出T碱基占7.5%,G碱基占92.5%;401位点检出T碱基占52.5%,G碱基占47.5%;494位点检出杂合子CG占100%.平和质组和对照组中CYP4501A2*1C401位点碱基分布有差异,且差异有统计学意义(P<0.05),平和质组CYP4501A2*1C401位点T碱基出现频率明显高于对照组(P<0.05),G碱基出现频率明显低于对照组(P<0.05)。结论:平和质酒精性股骨头坏死患者与非股骨头坏死正常人群在CYP4501A2*1C基因多态性位点碱基分布有差异,CYP4501A2*1C401位点T/G碱基的置换可能更易于形成酒精性股骨头坏死,在中医体质类型中CYP4501A2*1C401位点T/G碱基的置换可能更易于形成平和质酒精性股骨头坏死。 Objective:To explore the gene polymorphism of CYP4501A2*1Cin patients with alcoholic avascular necrosis of the femoral head of yin-yang balanced physique,and to investigate the correlation between CYP4501A2*1C,yin-yang balanced physique and alcoholic avascular necrosis of the femoral head.Methods:TCM constitution questionnaire survey was conducted among patients with alcoholic avascular necrosis of the femoral head.Those who belonged to yin-yang balanced physique were enrolled in the study for CYP4501A2*1Cgene polymorphism detection.Subjects without avascular necrosis of the femoral head were taken as control group.The analysis was performed by SPSS17.0software.Results:Five polymorphic loci were detected in the two groups.For patients belonging to yin-yang balanced physique,A base accounted for10.87% and G base accounted for 89.13% at 135 loci.One C base was inserted at 149 loci.T base accounted for 10.87%and G base accounted for 89.13%at 397 loci.T base accounted for 79.35%and G base accounted for 20.65%at 401 loci.Heterozygous GA accounted for 1.09%,homozygous GG accounted for 1.09%,and heterozygote CG was accounted for97.82% at 494 loci.As for control group,A base accounted for 12.5%and G base for 87.5%at 135 loci.No base was inserted at 149 loci.T base accounted for 7.5% and G base for 92.5% at 397 loci.T base accounted for 52.5% and G base for 47.5% at 494 loci.Heterozygous CG accounted for 100% at 494 loci.There was significant difference in the distribution of bases at CYP4501A2*1C401site between yin-yang balanced physique group and control group(P〈0.05).There were remarkably higher frequencies of T base in yin-yang balanced physique group than in control group(P〈0.05),while frequencies of G base apparently lower(P〈0.05).Conclusion:The distribution of bases at CYP4501A2*1C401site is different between normal population and patients of yin-yang balanced physique with alcoholic avascular necrosis of the femoral head.The substitution of T/G base at CYP4501A2*1C401site may be more vulnerable to the formation of alcoholic avascular necrosis of the femoral head.In TCM constitution types,the substitution of T/G base at CYP4501A2*1C401site may make it easier to form ethanol osteonecrosis of the femoral head in yin-yang balanced physique.
机构地区 甘肃省中医院
出处 《中国中医骨伤科杂志》 CAS 2014年第11期9-12,共4页 Chinese Journal of Traditional Medical Traumatology & Orthopedics
基金 国家自然科学基金面向上项目 非创伤性股骨头坏死中医体质类型及其相关基因多态性研究 批准号:81072821
关键词 酒精性股骨头坏死 中医体质 发病规律 CYP4501A2*1C 基因多态性 Alcoholic avascular necrosis TCM constitution Athogenesis CYP4501A2 * 1C Gene polymorphism
  • 相关文献

参考文献9

  • 1李子荣,张鹤山(整理),李子荣(整理).股骨头坏死诊断与治疗的专家建议[J].中华骨科杂志,2007,27(2):146-148. 被引量:284
  • 2中医体质分类与判定(ZYYXH/T157-2009)[J].世界中西医结合杂志,2009,4(4):303-304. 被引量:1237
  • 3PAVANELLO S, ALESSANDRA P, LUPIB S, et al. Influence of the genetic polymorphism in the 5 :-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers,Genetic Toxicology and Environmental Mutagenesis[J]. Mutat Res, 2005,587:59-66.
  • 4李蒙,朱传江.CYP3A4高表达细胞模型及其应用于药物代谢研究进展[J].中国药理学通报,2012,28(1):16-19. 被引量:8
  • 5NEBERT D W, RUSSELL D W. Clinical importance of the cyto chromes P450[J]. Lancet,2002,360, 1155-1162.
  • 6朱立勤,娄建石.细胞色素P450与药物代谢的研究现状[J].中国临床药理学与治疗学,2004,9(10):1081-1086. 被引量:51
  • 7ZHOUS F, YANG L P, ZHOU Z W, et al. In sights into the substrate specificity, inhibitors, reg/:Lation, and polymorphisms and the clinical impact of human eytochrome P450 1A2 [J]. AAPSJ,2009,11(3) :481-494.
  • 8CHEN X, WANG L, ZHI L, et al. The G-3113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese popptLation [J]. Clin Pharmacol Ther, 2005,78(3) : 249-259.
  • 9KANESHIRO Y,ODA Y,IWAKIRI K, et al. Low hepatic cyto chrome P450 3A activity is a risk for corticosteroid- induced osteo- necrosis[J]. Clin Pharmacol Ther,2006,80(4) :396-402.

二级参考文献49

  • 1[15]Dilmaghanian S, Gerber JG, Filler SG, Sanchez A, Gal J. Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4)by ketoconazole: Testosterone and methadone as substrates[ J].Chirality, 2004; 16(2) :79 - 85
  • 2[16]Lown KS,Thummel KE, Benedict PE, Shen DD, Turgeon DK,Berent S, et al. The erythromycin breath test predicts the clearance of midazolam[ J]. Clin Pbarmacol Ther, 1995;57( 1 ):16 - 24
  • 3[17]Turgeon DK, Normolle DP, Leichtman AB, Annesley TM,Smith DE, Watkins PB. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients[J].Clin Pharmcol Ther, 1992;52(5) :471 - 8
  • 4[18]Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK,Zaheer NA, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo [J]. Clin Pharmacol Ther, 2004; 75 ( 1 ): 89 - 100
  • 5[19]Pichard-Garcia L, Weaver RJ, Eckett N, Scarfe G, Fabre JM,Lucas C, et al. The olivacine derivatives 16020 (9-hydroxy-5,6-dimethyl-N- [2-( dimethylamino ) ethyl ]-6H-pyrido ( 4, 3-B )-carbazole-1-carboxamide) induces CYP1A and its own metabolism in human hepatocytes in primary culture [J ]. Drug Metab Dispos, 2004;32(1) :80 - 8
  • 6[20]Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM,Fleming I. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease [ J ]. Circulation, 2004; 109(2): 178 - 83
  • 7[21]Soga Y, Nishimura F, Ohtsuka Y, Araki H, Iwamoto Y, Naruishi H, et al. CYP2C polymorphisms, pheuytoin metabolism and gingival overgrowth in epileptic subjects[J]. Life Sci,2004;74(7) :827 - 34
  • 8[22]Tanaka E, Kurata N, Yasuhara H. Involvement of cytochrome P450 2C9, 2E1 and 3A4 in trimethadione N-demethylation in human microsomes[J]. J Clin Pharm Ther, 2003;28(6) :493-6
  • 9[23]Spina E, Scordo MG, D'Arrigo C. Metabolic drug interactions with new psychotropic agents [ J ]. Fundam Clin Pharmacol,2003; 17(5) :517 - 38
  • 10[24]Benetton S, Kameoka J, Tan A, Wachs T, Craighead H, Henion JD. Chip-based P450 drug metabolism coupled to electrospray ionization-mass spectrometry detection [ J]. Anal Chem,2003; 75 (23): 6430 - 6

共引文献1573

同被引文献77

引证文献6

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部